Parallel Advisors’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Parallel Advisors’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	3351
2021 Q4	$0	Hold	1	–	–	﹤0.01%	3352
2021 Q3	$0	Buy	+1	New	+$89	﹤0.01%	3319

Other funds holding NURO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallel Advisors's NURO Position: Q1 2022 in Review

Parallel Advisors sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2022, closing a stake of 1 share.

Parallel Advisors first reported a position in NURO in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 17 funds tracked by Wall St. Rank hold NURO as of Q1 2022.

Parallel Advisors reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Parallel Advisors sold 1 NeuroMetrix, Inc. Common Stock share in Q1 2022.
Parallel Advisors first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
Parallel Advisors's NeuroMetrix, Inc. Common Stock position peaked at $0 in Q4 2021.
17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.